Harvard Medical School and Cellectricon collaborates Around Whole-Genome RNAi Screening Technology
News Nov 26, 2008
Cellectricon has announced its collaboration with Harvard Medical School, the ICCB-Longwood Screening Facility. Harvard Medical School (ICCB-L) will utilize the Cellaxess®HT system, a system for high throughput transfection enabling reagent-free delivery of genetic material to a wide range of biologically relevant cell types.
“We are excited about the collaboration with Cellectricon and the opportunity we have to evaluate Cellaxess®HT for genome-wide RNAi delivery to biologically relevant cell types”, says Caroline Shamu, Director of ICCB-L.
“Cellectricon is extremely proud to collaborate with a world-class research institution such as Harvard Medical School (ICCB-L)”, says Jonas Ohlsson, CEO at Cellectricon. We look forward to jointly advance the RNAi research area by our technology, as we’re confident that Cellaxess®HT will aid in the generation of more relevant results from RNAi screening campaigns.”
Early Life Experiences Alter DNA Structure in the Adult BrainNews
Scientists report in the journal Science that the type of mothering a female mouse provides her pups actually changes their DNA.READ MORE
Early Life-Changing Experiences Also Change Your GenesNews
Factors in early life such as maternal care influence the number and modifications of certain 'jumping genes' - a finding that ties together nature and nurture.READ MORE